Analysis of Risk Factors for 24 Patients With COVID-19 Developing From Moderate to Severe Condition
Cellular and Infection Microbiology
Published on
Journal: Frontiers in Cellular and Infection Microbiology
[Category] Coronavirus, MERS, SARS,
Journal: Frontiers in Cellular and Infection Microbiology
[Category] Coronavirus, MERS, SARS,
[키워드] accompanied
age
albumin
Antiviral
antiviral drug
Antiviral treatment
Blood
blood glucose
changes
Characteristics
Chest CT
clinical
Clinical characteristics
Clinical data
clinical risk factor
clinical symptom
collected
college
Combination
condition
consolidation
contributed
COVID-19
COVID-19 patient
CRP
current
develop
Developing
evaluated
Evidence
Factor
Gender
GPT
ground-glass opacity
IL-6
imaging
Inflammatory
Inflammatory factor
interstitial
Intervention
Isolation
knowledge
lung
Lungs
Lymphocyte count
manifestation
moderate
moderate-to-severe COVID-19
Mortality
no significant difference
Particular
patchy
Patient
patients with moderate
plasma
Platelet
potential risk
Prognosis
reduction
respiratory frequency
Risk factors
severe
significant difference
significantly higher
significantly lower
statistically
statistically significant
statistically significant difference
suggested
t -value
two group
underlying disease
underlying diseases
urea
WBC
White blood cell
[DOI] 10.3389/fcimb.2020.548582 PMC 바로가기 [Article Type] Cellular and Infection Microbiology
[DOI] 10.3389/fcimb.2020.548582 PMC 바로가기 [Article Type] Cellular and Infection Microbiology